Top Longevity Scientists Gather to Debate NAD, Sirtuins and the Future of Aging
Eric Verdin, Morgan Levine, and Bette Yin Lacroix headline a 100-talk longevity conference covering NAD biology, epigenetic aging, and lifespan extension.
Summary
A major longevity conference is drawing attention with over 100 talks across four days, featuring some of the field's most prominent researchers. Eric Verdin of the Buck Institute will address sirtuins and NAD metabolism in the context of epigenetic aging — a topic with growing clinical relevance given the surge in NAD-boosting supplements. Morgan Levine of Altos Labs will explore computational and virtual modeling approaches to longevity science, reflecting the field's increasing reliance on AI and data-driven tools. Bette Yin Lacroix from Retro Bioscience will present on strategies for extending healthy lifespan, a company focused on rejuvenation biotechnology. For clinicians and health-conscious individuals alike, this convergence of leading voices signals where longevity research is heading — from molecular mechanisms to translatable interventions.
Detailed Summary
Longevity science rarely gets a moment where its most influential voices share a single stage, but a forthcoming conference featuring 100-plus talks over four days appears to be exactly that. The event is generating significant buzz in the longevity community, with a curated lineup that spans molecular biology, computational modeling, and translational medicine.
Eric Verdin, president and CEO of the Buck Institute for Research on Aging, is set to present on sirtuins, NAD metabolism, and the epigenetics of aging. Sirtuins are a family of proteins that regulate cellular health and stress responses, and their dependence on NAD+ has made NAD-boosting compounds like NMN and NR among the most discussed longevity supplements. Verdin's work sits at the intersection of basic science and clinical application, making his talk particularly anticipated.
Morgan Levine, a leading figure in biological age measurement and now a principal investigator at Altos Labs, will speak on what she calls 'the virtual world of longevity.' This likely refers to computational modeling, digital twins, or AI-driven approaches to understanding and predicting aging trajectories — a rapidly growing frontier in the field.
Bette Yin Lacroix of Retro Bioscience, a company backed by significant private funding and focused on rejuvenation technologies, will address strategies for extending healthy lifespan. Retro has been exploring autophagy enhancement and plasma-based interventions, among other approaches.
For clinicians and informed consumers, conferences like this serve as a leading indicator of where the science is heading before it reaches clinical guidelines or mainstream media. The convergence of epigenetics, computational biology, and rejuvenation biotech in a single program reflects the field's maturation.
Caveats apply: this summary is based on a social media post previewing the event, not published research or official conference proceedings.
Key Findings
- Eric Verdin will present on sirtuins and NAD metabolism, core mechanisms behind popular longevity supplements.
- Morgan Levine's talk suggests AI and computational modeling are becoming central tools in aging research.
- Retro Bioscience's Lacroix will address practical strategies for extending healthy lifespan.
- 100-plus talks over four days signals longevity science is expanding rapidly across multiple disciplines.
- Conference previews from KOLs on X are an early signal of emerging research directions before publication.
Methodology
This content is a social media post by longevity commentator Adam Gries previewing an upcoming conference. No peer-reviewed data or study methodology is present. Information is limited to speaker names, affiliations, and talk titles.
Study Limitations
This summary is based solely on a social media post, not published research or official conference materials. Speaker topics are described only by brief titles, so actual content and findings are unknown. No peer-reviewed evidence is presented or evaluated here.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.